1	Chung-Kang	_	_	NNP	_	_	_	_	_
2	Peng	_	_	NNP	_	_	_	_	_


1	Chung-Kang	_	_	NNP	_	_	_	_	_


1	Peng	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	Director	_	_	NNP	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	Center	_	_	NNP	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	Dynamical	_	_	NNP	_	_	_	_	_
10	Biomarkers	_	_	NNPS	_	_	_	_	_
11	at	_	_	IN	_	_	_	_	_
12	Beth	_	_	NNP	_	_	_	_	_
13	Israel	_	_	NNP	_	_	_	_	_
14	Deaconess	_	_	NNP	_	_	_	_	_
15	Medical	_	_	NNP	_	_	_	_	_
16	Center	_	_	NNP	_	_	_	_	_
17	/	_	_	SYM	_	_	_	_	_
18	Harvard	_	_	NNP	_	_	_	_	_
19	Medical	_	_	NNP	_	_	_	_	_
20	School	_	_	NNP	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	BIDMC/HMS	_	_	NNP	_	_	_	_	_
23	)	_	_	-RRB-	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_
25	[	_	_	-LRB-	_	_	_	_	_
26	1	_	_	CD	_	_	_	_	_
27	]	_	_	-RRB-	_	_	_	_	_


1	Under	_	_	IN	_	_	_	_	_
2	his	_	_	PRP$	_	_	_	_	_
3	direction	_	_	NN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	Center	_	_	NNP	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	Dynamical	_	_	NNP	_	_	_	_	_
8	Biomarkers	_	_	NNPS	_	_	_	_	_
9	researches	_	_	VBZ	_	_	_	_	_
10	fundamental	_	_	JJ	_	_	_	_	_
11	theories	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	novel	_	_	JJ	_	_	_	_	_
14	computational	_	_	JJ	_	_	_	_	_
15	algorithms	_	_	NNS	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	characterizing	_	_	VBG	_	_	_	_	_
18	physiological	_	_	JJ	_	_	_	_	_
19	states	_	_	NNS	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	terms	_	_	NNS	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	their	_	_	PRP$	_	_	_	_	_
24	dynamical	_	_	JJ	_	_	_	_	_
25	properties	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	He	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	currently	_	_	RB	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	K.	_	_	NNP	_	_	_	_	_
7	-T	_	_	NNP	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	Li	_	_	NNP	_	_	_	_	_
2	Visiting	_	_	NNP	_	_	_	_	_
3	Chair	_	_	NNP	_	_	_	_	_
4	Professor	_	_	NNP	_	_	_	_	_
5	at	_	_	IN	_	_	_	_	_
6	National	_	_	NNP	_	_	_	_	_
7	Central	_	_	NNP	_	_	_	_	_
8	University	_	_	NNP	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	NCU	_	_	NNP	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	Visiting	_	_	NNP	_	_	_	_	_
14	Chair	_	_	NNP	_	_	_	_	_
15	Professor	_	_	NNP	_	_	_	_	_
16	at	_	_	IN	_	_	_	_	_
17	National	_	_	NNP	_	_	_	_	_
18	Chiao	_	_	NNP	_	_	_	_	_
19	Tung	_	_	NNP	_	_	_	_	_
20	University	_	_	NNP	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	NCTU	_	_	NNP	_	_	_	_	_
23	)	_	_	-RRB-	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	Taiwan	_	_	NNP	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	Visiting	_	_	VBG	_	_	_	_	_
29	Professor	_	_	NNP	_	_	_	_	_
30	at	_	_	IN	_	_	_	_	_
31	China	_	_	NNP	_	_	_	_	_
32	Academy	_	_	NNP	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	Chinese	_	_	NNP	_	_	_	_	_
35	Medical	_	_	NNP	_	_	_	_	_
36	Sciences	_	_	NNPS	_	_	_	_	_
37	in	_	_	IN	_	_	_	_	_
38	China	_	_	NNP	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	During	_	_	IN	_	_	_	_	_
2	2012-2014	_	_	CD	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	he	_	_	PRP	_	_	_	_	_
5	served	_	_	VBD	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	founding	_	_	VBG	_	_	_	_	_
9	Dean	_	_	NNP	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	College	_	_	NNP	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	Health	_	_	NNP	_	_	_	_	_
15	Sciences	_	_	NNPS	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	Technology	_	_	NNP	_	_	_	_	_
18	at	_	_	IN	_	_	_	_	_
19	NCU	_	_	NNP	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	Taiwan	_	_	NNP	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Research	_	_	NN	_	_	_	_	_


1	Biomarker	_	_	NN	_	_	_	_	_
2	development	_	_	NN	_	_	_	_	_


1	Peng	_	_	NNP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	extensive	_	_	JJ	_	_	_	_	_
4	expertise	_	_	NN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	statistical	_	_	JJ	_	_	_	_	_
7	physics	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	its	_	_	PRP$	_	_	_	_	_
10	application	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	study	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	physiological	_	_	JJ	_	_	_	_	_
16	measures	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Along	_	_	IN	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	fellow	_	_	JJ	_	_	_	_	_
4	collaborators	_	_	NNS	_	_	_	_	_
5	he	_	_	PRP	_	_	_	_	_
6	has	_	_	VBZ	_	_	_	_	_
7	developed	_	_	VBN	_	_	_	_	_
8	many	_	_	JJ	_	_	_	_	_
9	novel	_	_	JJ	_	_	_	_	_
10	techniques	_	_	NNS	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	this	_	_	DT	_	_	_	_	_
13	area	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	including	_	_	VBG	_	_	_	_	_
16	:	_	_	:	_	_	_	_	_
17	Detrended	_	_	JJ	_	_	_	_	_
18	fluctuation	_	_	NN	_	_	_	_	_
19	analysis	_	_	NN	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	DFA	_	_	NN	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	which	_	_	WDT	_	_	_	_	_
24	is	_	_	VBZ	_	_	_	_	_
25	based	_	_	VBN	_	_	_	_	_
26	on	_	_	IN	_	_	_	_	_
27	statistical	_	_	JJ	_	_	_	_	_
28	physics	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	measures	_	_	VBZ	_	_	_	_	_
31	fractal	_	_	JJ	_	_	_	_	_
32	properties	_	_	NNS	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	physiologic	_	_	JJ	_	_	_	_	_
35	signals	_	_	NNS	_	_	_	_	_
36	(	_	_	-LRB-	_	_	_	_	_
37	cited	_	_	VBN	_	_	_	_	_
38	more	_	_	JJR	_	_	_	_	_
39	than	_	_	IN	_	_	_	_	_
40	6,500	_	_	CD	_	_	_	_	_
41	times	_	_	NNS	_	_	_	_	_
42	)	_	_	-RRB-	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_
44	[	_	_	-LRB-	_	_	_	_	_
45	2	_	_	CD	_	_	_	_	_
46	]	_	_	-RRB-	_	_	_	_	_
47	[	_	_	-LRB-	_	_	_	_	_
48	3	_	_	CD	_	_	_	_	_
49	]	_	_	-RRB-	_	_	_	_	_
50	Multiscale	_	_	NN	_	_	_	_	_
51	entropy	_	_	NN	_	_	_	_	_
52	(	_	_	-LRB-	_	_	_	_	_
53	MSE	_	_	NNP	_	_	_	_	_
54	)	_	_	-RRB-	_	_	_	_	_
55	which	_	_	WDT	_	_	_	_	_
56	measures	_	_	VBZ	_	_	_	_	_
57	the	_	_	DT	_	_	_	_	_
58	complexity	_	_	NN	_	_	_	_	_
59	of	_	_	IN	_	_	_	_	_
60	physiological	_	_	JJ	_	_	_	_	_
61	time-series	_	_	NNS	_	_	_	_	_
62	(	_	_	-LRB-	_	_	_	_	_
63	cited	_	_	VBN	_	_	_	_	_
64	more	_	_	JJR	_	_	_	_	_
65	than	_	_	IN	_	_	_	_	_
66	2,600	_	_	CD	_	_	_	_	_
67	times	_	_	NNS	_	_	_	_	_
68	)	_	_	-RRB-	_	_	_	_	_
69	.	_	_	.	_	_	_	_	_
70	[	_	_	-LRB-	_	_	_	_	_
71	4	_	_	CD	_	_	_	_	_
72	]	_	_	-RRB-	_	_	_	_	_
73	[	_	_	-LRB-	_	_	_	_	_
74	5	_	_	CD	_	_	_	_	_
75	]	_	_	-RRB-	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	algorithm	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	based	_	_	VBN	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	information	_	_	NN	_	_	_	_	_
7	theory	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	statistical	_	_	JJ	_	_	_	_	_
10	physics	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	linguistic	_	_	JJ	_	_	_	_	_
14	analysis	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	symbolic	_	_	JJ	_	_	_	_	_
17	sequences	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_
19	[	_	_	-LRB-	_	_	_	_	_
20	6	_	_	CD	_	_	_	_	_
21	]	_	_	-RRB-	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	applied	_	_	VBN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	bio-medical	_	_	JJ	_	_	_	_	_
7	signals	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	human	_	_	JJ	_	_	_	_	_
10	languages	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	DNA	_	_	NN	_	_	_	_	_
14	sequences	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Prof.	_	_	NNP	_	_	_	_	_
2	Peng	_	_	NNP	_	_	_	_	_
3	received	_	_	VBD	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	Calvin	_	_	NNP	_	_	_	_	_
6	&	_	_	CC	_	_	_	_	_
7	Rose	_	_	NNP	_	_	_	_	_
8	G.	_	_	NNP	_	_	_	_	_
9	Hoffman	_	_	NNP	_	_	_	_	_
10	Prize	_	_	NNP	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	2004	_	_	CD	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	his	_	_	PRP$	_	_	_	_	_
15	contribution	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	applying	_	_	VBG	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	algorithm	_	_	NN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	analyze	_	_	VB	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	authorship	_	_	NN	_	_	_	_	_
24	issue	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	Shakespeare	_	_	NNP	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_
28	[	_	_	-LRB-	_	_	_	_	_
29	7	_	_	CD	_	_	_	_	_
30	]	_	_	-RRB-	_	_	_	_	_


1	ECG-based	_	_	JJ	_	_	_	_	_
2	cardiopulmonary	_	_	JJ	_	_	_	_	_
3	coupling	_	_	NN	_	_	_	_	_
4	analysis	_	_	NN	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	study	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	sleep	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_
11	[	_	_	-LRB-	_	_	_	_	_
12	8	_	_	CD	_	_	_	_	_
13	]	_	_	-RRB-	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	algorithm	_	_	NN	_	_	_	_	_
3	has	_	_	VBZ	_	_	_	_	_
4	been	_	_	VBN	_	_	_	_	_
5	patented	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	U.S.	_	_	NNP	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	Europe	_	_	NNP	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	improved	_	_	JJ	_	_	_	_	_
3	algorithm	_	_	NN	_	_	_	_	_
4	that	_	_	WDT	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	based	_	_	VBN	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	heart	_	_	NN	_	_	_	_	_
9	rate	_	_	NN	_	_	_	_	_
10	variability	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	detect	_	_	VB	_	_	_	_	_
13	sleep-disordered	_	_	JJ	_	_	_	_	_
14	breathing	_	_	NN	_	_	_	_	_
15	has	_	_	VBZ	_	_	_	_	_
16	received	_	_	VBN	_	_	_	_	_
17	FDA	_	_	NNP	_	_	_	_	_
18	approvals	_	_	NNS	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	U.S.	_	_	NNP	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	Taiwan	_	_	NNP	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	China	_	_	NNP	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	index	_	_	NN	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	dynamic	_	_	JJ	_	_	_	_	_
5	cerebral	_	_	JJ	_	_	_	_	_
6	autoregulation	_	_	NN	_	_	_	_	_
7	.	_	_	.	_	_	_	_	_
8	[	_	_	-LRB-	_	_	_	_	_
9	9	_	_	CD	_	_	_	_	_
10	]	_	_	-RRB-	_	_	_	_	_


1	Peng	_	_	NNP	_	_	_	_	_
2	's	_	_	POS	_	_	_	_	_
3	publications	_	_	NNS	_	_	_	_	_
4	have	_	_	VBP	_	_	_	_	_
5	been	_	_	VBN	_	_	_	_	_
6	cited	_	_	VBN	_	_	_	_	_
7	more	_	_	JJR	_	_	_	_	_
8	than	_	_	IN	_	_	_	_	_
9	37,000	_	_	CD	_	_	_	_	_
10	times	_	_	NNS	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	h-index	_	_	NN	_	_	_	_	_
13	:	_	_	:	_	_	_	_	_
14	73	_	_	CD	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_
17	[	_	_	-LRB-	_	_	_	_	_
18	10	_	_	CD	_	_	_	_	_
19	]	_	_	-RRB-	_	_	_	_	_


1	He	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	recipient	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	10-Years	_	_	NNP	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	2002-2012	_	_	CD	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	Innovator	_	_	NNP	_	_	_	_	_
12	Award	_	_	NNP	_	_	_	_	_
13	from	_	_	IN	_	_	_	_	_
14	BIDMC	_	_	NNP	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	2013	_	_	CD	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	Distinguished	_	_	NNP	_	_	_	_	_
20	Alumnus	_	_	NNP	_	_	_	_	_
21	Award	_	_	NNP	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	NCTU	_	_	NNP	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	2015	_	_	CD	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Physionet	_	_	NNP	_	_	_	_	_


1	Peng	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	one	_	_	CD	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	founding	_	_	VBG	_	_	_	_	_
7	members	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	PhysioNet	_	_	NNP	_	_	_	_	_
11	resource	_	_	NN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	PhysioNet	_	_	NNP	_	_	_	_	_
2	offers	_	_	VBZ	_	_	_	_	_
3	free	_	_	JJ	_	_	_	_	_
4	web	_	_	NN	_	_	_	_	_
5	access	_	_	NN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	large	_	_	JJ	_	_	_	_	_
8	collections	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	recorded	_	_	VBN	_	_	_	_	_
11	physiologic	_	_	JJ	_	_	_	_	_
12	signals	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	related	_	_	VBN	_	_	_	_	_
15	open-source	_	_	JJ	_	_	_	_	_
16	software	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	PhysioNet	_	_	NNP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	more	_	_	JJR	_	_	_	_	_
4	than	_	_	IN	_	_	_	_	_
5	1	_	_	CD	_	_	_	_	_
6	million	_	_	CD	_	_	_	_	_
7	visitors	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	more	_	_	JJR	_	_	_	_	_
11	than	_	_	IN	_	_	_	_	_
12	200	_	_	CD	_	_	_	_	_
13	TB	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	data	_	_	NNS	_	_	_	_	_
16	downloaded	_	_	VBN	_	_	_	_	_
17	each	_	_	DT	_	_	_	_	_
18	year	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Biomedical	_	_	JJ	_	_	_	_	_
2	device	_	_	NN	_	_	_	_	_
3	development	_	_	NN	_	_	_	_	_


1	Jointly	_	_	RB	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	HTC	_	_	NNP	_	_	_	_	_
5	Corporation	_	_	NNP	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	Peng	_	_	NNP	_	_	_	_	_
8	led	_	_	VBD	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	team	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	called	_	_	VBN	_	_	_	_	_
13	Dynamical	_	_	NNP	_	_	_	_	_
14	Biomarkers	_	_	NNP	_	_	_	_	_
15	Group	_	_	NNP	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	DBG	_	_	NNP	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	physicians	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	scientists	_	_	NNS	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	engineers	_	_	NNS	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	compete	_	_	VB	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	Qualcomm	_	_	NNP	_	_	_	_	_
31	Tricorder	_	_	NNP	_	_	_	_	_
32	XPRIZE	_	_	NNP	_	_	_	_	_
33	international	_	_	JJ	_	_	_	_	_
34	competition	_	_	NN	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	biggest	_	_	JJS	_	_	_	_	_
38	biomedical	_	_	JJ	_	_	_	_	_
39	prize	_	_	NN	_	_	_	_	_
40	in	_	_	IN	_	_	_	_	_
41	history	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	Since	_	_	IN	_	_	_	_	_
2	its	_	_	PRP$	_	_	_	_	_
3	announcement	_	_	NN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	2012	_	_	CD	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	this	_	_	DT	_	_	_	_	_
8	XPRIZE	_	_	NNP	_	_	_	_	_
9	attracted	_	_	VBD	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	interest	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	more	_	_	JJR	_	_	_	_	_
14	than	_	_	IN	_	_	_	_	_
15	300	_	_	CD	_	_	_	_	_
16	teams	_	_	NNS	_	_	_	_	_
17	around	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	world	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	goal	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	competition	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	develop	_	_	VB	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	mobile	_	_	JJ	_	_	_	_	_
11	solution	_	_	NN	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	end-patients	_	_	NNS	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	diagnose	_	_	VB	_	_	_	_	_
16	their	_	_	PRP$	_	_	_	_	_
17	health	_	_	NN	_	_	_	_	_
18	conditions	_	_	NNS	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	monitor	_	_	VB	_	_	_	_	_
21	their	_	_	PRP$	_	_	_	_	_
22	vital	_	_	JJ	_	_	_	_	_
23	signs	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	Tricorder	_	_	NNP	_	_	_	_	_
3	name	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	based	_	_	VBN	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	medical	_	_	JJ	_	_	_	_	_
9	diagnostic	_	_	JJ	_	_	_	_	_
10	device	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	Star	_	_	NNP	_	_	_	_	_
13	Trek	_	_	NNP	_	_	_	_	_
14	fame	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	After	_	_	IN	_	_	_	_	_
2	4	_	_	CD	_	_	_	_	_
3	years	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	competition	_	_	NN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	several	_	_	JJ	_	_	_	_	_
8	rounds	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	eliminations	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	DBG	_	_	NNP	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	one	_	_	CD	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	top	_	_	JJ	_	_	_	_	_
18	2	_	_	CD	_	_	_	_	_
19	teams	_	_	NNS	_	_	_	_	_
20	that	_	_	WDT	_	_	_	_	_
21	advanced	_	_	VBD	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	final	_	_	JJ	_	_	_	_	_
25	round	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	competition	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	received	_	_	VBD	_	_	_	_	_
31	a	_	_	DT	_	_	_	_	_
32	$	_	_	SYM	_	_	_	_	_
33	1	_	_	CD	_	_	_	_	_
34	million	_	_	CD	_	_	_	_	_
35	prize	_	_	NN	_	_	_	_	_
36	for	_	_	IN	_	_	_	_	_
37	its	_	_	PRP$	_	_	_	_	_
38	achievement	_	_	NN	_	_	_	_	_
39	in	_	_	IN	_	_	_	_	_
40	April	_	_	NNP	_	_	_	_	_
41	2017	_	_	CD	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_
43	[	_	_	-LRB-	_	_	_	_	_
44	11	_	_	CD	_	_	_	_	_
45	]	_	_	-RRB-	_	_	_	_	_

